H. Tran, T. Vo, and M. N. Nguyen, “High expression of DIMT1 correlates with poor prognosis and high risk of bone metastasis in breast cancer patients”, Science and Technology Development Journal: Health Sciences, vol. 1, no. 2, pp. 52-63, Feb. 2021.